ÃâÒßѧÊÔÌâ
e-CNQnO~ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
T~i%j@Q.6 1. Fas(CD95)/FasL
,hpH!J'5f/ 2. common chain of cytokine receptor
KG
V.S 3 . TCR/CD3 complex
mF[o*N* 4. negaive selection of thymocytes
Q00R<hu@F 5. artificial active immune
\H Wcd| 6. anti-idiotypic
B :.@Qi^ 7. IgSF
sU) TXL'_! 8. Integrin
!c3```* 9. chemokine
K0w<[CO 10. B7/CD28
A6Ghj{~ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
9R9__w; 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
6g5PM4\ 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
NH7`5mF$ 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
aWyUu/g<A` 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
e^j<jV`1
4p.^'2m 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
)PR3s1S^ µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
"(s6aqO$ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
kOw=c Gt 1. B7/CD28
zVSx$6eiU 2. Th1 subset
rh@r\H@j 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
%BUEX 4. antibody affinity maturation
EXuLSzQwv 5. AP-1
D^Te%qnW 6. single chain variable fragment£¨ScFv£©
O~V1Ywfq7^ 7. NK cell receptor
{m[s<A( 8. Zinkernagel-Doherty phenomenon
Yc^%zxub 9. Ig fold
6?N4l ]l 10. CD40/CD40L
\V,c]I
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
j~bAbOX12
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
i[\w%(83Fi 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
(S`6Q 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
NUCiY\td Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
6B0#4Qrv 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
H$!+A 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
MaO"#{i 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
# ly@;!M Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
&iNwvA%9D £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
4S|=/f Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
8-m
3e 1.Co-stimulators (or co-stimulating molecules)
xACdZB( 2.NK-kB
r`jWp\z 3.Immunoglobulin superfamily
t6+YXjXK 4.antigen-presenting cell (APC)
qz!Ph5( 5.death domain
p~&BChBl!= 6.CCR and CXCR
_%~$'Hy 7.Lectin (or mitogen)
.6
3=(o 8.Clusters of differentiation, CD)
qj!eLA-aD 9.B7 family
7\ypW $Ot 10.Cytotoxic T lymphocyte, CTL)
o:"anHs 11.IL-15 and IL-15 receptor (IL-15R)
6.5wZN9<| 12.MHC restriction
g JjN<&, 13.Affinity-chromatography
DIaYo4 14.Cyctosprin A, CsA
nPN?kO=] 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
Tde0 ~j} ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
/*$hx @ih 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
vi!YN|}\ 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
c3)C{9T]( 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
4nqoZk^R Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
j}:~5 |. ÃâÒßѧרҵ£º
sbj";h=E 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
H={&3poBz Ïû»¯ÄÚ¿Æ£º
+oc
>S 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
Nc)J18 ѪҺ²¡Ñ§×¨Òµ£º
p
`F9Amb 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
ka"337H Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
?F7o!B (רҵ»ù´¡: ÃâÒßѧ)
+GF#?X0^ Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
cXnKCzSxZq 1. ADCC(antibody dependent cell-mediated cytotoxicity)
l@JSK; 2. »·æß¾úËØ(cyclosporin)
p|+B3 3. KIR(killer cell inhibitory receptor)
B@y(. 4. HLDA(human leucocyte differentiation antigen)
::5E 8919 5. Interleukin 18(IL-18)
6KZf%)$ 6. ÕûºÏËØ(integrin)
1f'Hif*r_X 7. Fas/FasL
tK(g-u0N`( 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
44ed79ly0) 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
ccFn.($p?, 10. Th1/Th2
D*PYr{z' 11. »ùÒòÒßÃç(DNAÒßÃç)
errH>D~ 12. chemokines and chemokine receptor
Ih}1%Jq 13. ÃâÒßÄÍÊÜ
FR[ B v 14. ¹²´Ì¼¤·Ö×Ó
bx4'en# 15. ËÀÍö½á¹¹Óò(death domain)
H(
jXI ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
Y-mK+12 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
g*UMG> 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
M:KbD| £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
/iC;%r1L £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
7dG79H £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
iD38\XNMV £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
qBV x
6MI 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
OLGBt Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
K,'*Dz ÎÊ´ðÌâ(ÿÌâ25·Ö)
im7nJQ^H$q 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
7
;@ST`cC 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
0Sq][W= 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
mR\`DltoV 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£